Anjali Chhatre

Anjali Chhatre provides strategic healthcare advice to life sciences, health plans, and pharmaceutical clients, helping them navigate the complex legislative and regulatory policy environment.

Prior to joining Avalere, Anjali was associate health policy counsel under US Senator Pat Roberts. As an advisor on health policy, Anjali has extensive experience working on issues in and with both the Senate Health, Education, Labor, and Pensions and Finance Committees. She advised on policy issues such as Medicare and Medicaid programs, Food & Drug Administration approval protocols, user fee acts, biosimilar and generic pricing and compliance, and Orange and Purple Book modifications. During her tenure, Anjali was involved in a variety of major legislative efforts, including the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, the Lower Health Care Costs Act, the Prescription Drug Pricing Reduction Act of 2019, and the Supporting Older Americans Act of 2020.

Anjali holds an undergraduate degree from Creighton University, a JD from Suffolk University Law School, and an LLM in Health Policy and the Law from Northeastern University School of Law. She is a licensed attorney in the District of Columbia.

Authored Content

As Congress considers the bipartisan infrastructure package and budget reconciliation agenda, the coming months are likely to include debate on what could be the most significant federal healthcare legislation in over a decade. Additionally, the Biden administration is expected to release several important healthcare rules this fall, including the details necessary to implement the new law banning surprise billing and regulations to protect and strengthen Medicaid and the Affordable Care Act (ACA).